Evidence map›Paper›PMID 24816478›Full record

ArticleNMR in biomedicine2014

3D MRI of impaired hyperpolarized 129Xe uptake in a rat model of pulmonary fibrosis.

Zackary I Cleveland, Rohan S Virgincar, Yi Qi, Scott H Robertson, Simone Degan, Bastiaan Driehuys

Open access · greenAbstract read
In one paragraph

Article in NMR in biomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 45 citations in OpenAlex.

  1. Targeting the epithelium in pulmonary fibrosis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Design and Implementation of a Multi-Center Trial ofJournal of magnetic resonance imaging : JMRI · 2025
    Article
  3. Parahydrogen-Hyperpolarized Propane-The journal of physical chemistry. A · 2025
    Article
  4. Article
  5. Mapping the amplitude and phase of dissolvedMagnetic resonance in medicine · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Preclinical MRI Using HyperpolarizedMolecules (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Mapping cardiopulmonary dynamics within the microvasculature of the lungs using dissolvedJournal of applied physiology (Bethesda, Md. : 1985) · 2020
    Article
  16. QuantitativeScientific reports · 2020
    Article
  17. Annals of the American Thoracic Society · 2020
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Zackary I ClevelandCenter for In Vivo Microscopy, Department of Radiology, Duke University Medical Center, Durham, NC, USA.
Rohan S Virgincar
Yi Qi
Scott H Robertson
Simone Degan
Bastiaan Driehuys
Duke Medical Center · USCincinnati Children's Hospital Medical Center · USDuke University · USDuke University Hospital · US

Funding

INTEGRATED CENTER FOR IN VIVO MICROSCOPYP41EB015897 · NIBIB · DUKE UNIVERSITY · PI JOHNSON, GEORGE ALLAN · 2012 to 2017
$7.4M
Early Detection of Changes in Pulmonary Gas Exchange by Hyperpolarized Xe MRIR01HL105643 · NHLBI · DUKE UNIVERSITY · PI Bastiaan Driehuys · 2011 to 2026
$6.7M
Sensitive and Specific Molecular Imaging of Pulmonary NodulesR01CA142842 · NCI · DUKE UNIVERSITY · PI BRANCA, ROSA TAMARA, DRIEHUYS, BASTIAAN · 2010 to 2014
$1.5M
Time-Resolved 129Xe Ventilation-Perfusion MRI in Models of Acute Lung InjuryK99HL111217 · NHLBI · DUKE UNIVERSITY · PI CLEVELAND, ZACKARY I · 2012 to 2013
$168k
NCI NIH HHS R01 CA142842NCI NIH HHS R01-CA-142842NHLBI NIH HHS 1K99-HL-111217-01A1NHLBI NIH HHS K99 HL111217NHLBI NIH HHS R01 HL105643NHLBI NIH HHS R01HL105643NIBIB NIH HHS P41 EB015897
6 · The paper itself

Abstract

A variety of pulmonary pathologies, in particular interstitial lung diseases, are characterized by thickening of the pulmonary blood-gas barrier, and this thickening results in reduced gas exchange. Such diffusive impairment is challenging to quantify spatially, because the distributions of the metabolically relevant gases (CO2 and O2) cannot be detected directly within the lungs. Hyperpolarized (HP) (129)Xe is a promising surrogate for these metabolic gases, because MR spectroscopy and imaging allow gaseous alveolar (129)Xe to be detected separately from (129)Xe dissolved in the red blood cells (RBCs) and the adjacent tissues, which comprise blood plasma and lung interstitium. Because (129)Xe reaches the RBCs by diffusing across the same barrier tissues (blood plasma and interstitium) as O2, barrier thickening will delay (129)Xe transit and, thus, reduce RBC-specific (129)Xe MR signal. Here we have exploited these properties to generate 3D, MR images of (129)Xe uptake by the RBCs in two groups of rats. In the experimental group, unilateral fibrotic injury was generated prior to imaging by instilling bleomycin into one lung. In the control group, a unilateral sham instillation of saline was performed. Uptake of (129)Xe by the RBCs, quantified as the fraction of RBC signal relative to total dissolved (129)Xe signal, was significantly reduced (P = 0.03) in the injured lungs of bleomycin-treated animals. In contrast, no significant difference (P = 0.56) was observed between the saline-treated and untreated lungs of control animals. Together, these results indicate that 3D MRI of HP (129)Xe dissolved in the pulmonary tissues can provide useful biomarkers of impaired diffusive gas exchange resulting from fibrotic thickening.

Indexed as

Imaging, Three-DimensionalMagnetic Resonance ImagingAnimalsBleomycinDisease Models, AnimalErythrocytesFemaleLungPulmonary FibrosisRats, Inbred F344Reproducibility of ResultsSignal Processing, Computer-AssistedSodium ChlorideSpectrum AnalysisXenon IsotopesBleomycinSodium ChlorideXenon Isotopeschemical shiftdiffusion impairmentDixon imaginggas exchangeILDinterstitial lung diseaseIPFxenon-129

Identifiers

PMID24816478
PMCPMC4229493
OpenAlexW1849412223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.